Systematic literature review of the impact of psychiatric pharmacists: SLR2

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Introduction: Pharmacists managing psychotropic medications improve clinical and patient-level outcomes across a variety of healthcare settings and diagnoses. The Systematic Literature Review (SLR) Committee of the American Association of Psychiatric Pharmacists published the original paper, known as SLR1, in 2024. This paper served as a comprehensive database, cataloguing the impact of psychiatric pharmacists. The purpose of this paper was to expand the database from SLR1. Methods: A second systematic literature review (SLR2) from January 1, 1961, to December 31, 2024, was conducted using PubMed and search terms based on a previous paper (SLR1). The inclusion criteria required pharmacist intervention focused on psychiatric diagnoses and/or psychotropic medications, as well as evaluation of patient-level outcomes. Exclusion criteria were met if there was no pharmacist intervention, no psychiatric disorder treatment, no clinical outcomes, no original research, no access to full text, and/or no English-language version available. Results: A total of 5883 articles were identified for possible inclusion, with only 466 remaining after screening by title and Another 374 were excluded on the first full-text review. The remaining articles underwent a second full-text review, resulting in 52 articles meeting the inclusion criteria. SLR1 and SLR2 combine for 246 included articles. Discussion: Publication of articles displaying the impact of psychiatric pharmacists has slowed over the past two years, but the overall outcomes were positive, as was also seen in SLR1. The cumulative results of SLR1 and SLR2 support the need for standardization of outcomes and stronger study designs to fully demonstrate the benefit of psychiatric pharmacists.

This publication has 54 references indexed in Scilit: